¿Cuándo una intervención es fútil? | 02 JUN 14

10 preguntas (y respuestas) sobre la futilidad médica

La intervención médica excesiva (en términos de esfuerzo y económicos) con escasa perspectiva de alterar la evolución médica del paciente.
Autor/a: Dres. Swetz KM, Burkle CM Mayo Clin Proc. 2014 Apr 9. pii: S0025-6196(14)00163-3
INDICE:  1.  | 2. Referencias
Referencias

1. Breslin JM, MacRae SK, Bell J, Singer PA. Top 10 health care ethics challenges facing the public: views of Toronto bioethicists. BMC Med Ethics. 2005; 6:E5.
2. Pope TM. Surrogate selection: an increasingly viable, but limited, solution to intractable futility disputes. Saint Louis U Law Rev. 2010; 3:183-252.
3. Mueller PS, Hook CC. Technological and treatment imperatives, life-sustaining technologies, and associated ethical and social challenges. Mayo Clin Proc. 2013; 88(7):641-644.
4. Merriam-Webster Dictionary. http://www.merriam-webster.com/dictionary/futile  Accessed July 31, 2013.
5. Lo B. Resolving Ethical Dilemmas: A Guide for Clinicians. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2013:71-76.
6. Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990; 112(12): 949-954.
7. Youngner SJ. Who defines futility? JAMA. 1988; 260(14):2094-2095.
8. Kwiecinski M. To be or not to be, should doctors decide? Ethical and legal aspects of medical futility policies. Marquette Elder’s Advisor. 2006; 7(2):Article 7.
9. Knaus W, Wagner D, Draper E. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients: implications. Crit Care Med. 1989; 17(12 pt 2): S219-S221.
10. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991; 100(6):1619-1636.
11. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med. 2006; 34(5):1297-1310.
12. Berge KH, Maiers DR, Schreiner DP, et al. Resource utilization and outcome in gravely ill intensive care unit patients with predicted in-hospital mortality rates of 95% or higher by APACHE III scores: the relationship with physician and family expectations. Mayo Clin Proc. 2005; 80(2):166-173.
13. Keegan MT, Gajic O, Afessa B. Severity of illness scoring systems in the intensive care unit. Crit Care Med. 2011; 39(1):163-169.
14. Diem SJ, Lantos JD, Tulsky JA. Cardiopulmonary resuscitation on television: miracles and misinformation. N Engl J Med. 1996; 334(24):1578-1582.
15. Jones GK, Brewer KL, Garrison HG. Public expectations of survival following cardiopulmonary resuscitation. Acad Emerg Med. 2000; 7(1):48-53.
16. Stix M. Un-extraordinary measures: stats show CPR often falls flat. CNN Health. 2013. http://www.cnn.com/2013/07/10/health/cpr-lifesaving-stats  Accessed July 31, 2013.
17. Tweet MS, Schears GJ, Cassar A, Sheldon SH, McGlinch BP, Sandhu GS. Emergency cardiac support with extracorporeal membrane oxygenation for cardiac arrest. Mayo Clin Proc. 2013; 88(7):761-765.
18. White RD, Goodman BW, Arendt CJ. Neurologically intact survival following prolonged cardiac arrest monitored with continuous capnography and subsequent treatment with therapeutic hypothermia. Mayo Clin Proc. 2011; 86(11):1124-1125.
19. White RD, Goodman BW, Svoboda MA. Neurologic recovery following prolonged out-of-hospital cardiac arrest with resuscitation guided by continuous capnography. Mayo Clin Proc. 2011; 86(6):544-548.
20. Automatic CPR device saves life of woman who was clinically dead for 42 minutes. ABC News Australia. 2013. http://www.abc.net.au/news/2013-08-19/automatic-cpr-device-saves-lifeof-woman-who-was-clinically-dea/4896722. Accessed August
27, 2013.
21. Lupkin S. Ohio Man Declared Dead Comes Back to Life. ABC News. 2013. http://abcnews.go.com/Health/ohio-man-declareddead-back-life/story?id¼20027401
Accessed August 27, 2013.
22. Mobley MJ, Rady MY, Verheijde JL, Patel B, Larson JS. The relationship between moral distress and perception of futile care in the critical care unit. Intensive Crit Care Nurs. 2007;23(5): 256-263.
23. Wijdicks EF, Wijdicks MF. Coverage of coma in headlines of US newspapers from 2001 through 2005. Mayo Clin Proc. 2006; 81(10):1332-1336.
24. Wijdicks EF, Cranford RE. Clinical diagnosis of prolonged states of impaired consciousness in adults. Mayo Clin Proc. 2005; 80(8):1037-1046.
25. Wijdicks EF. Minimally conscious state vs. persistent vegetative state: the case of Terry (Wallis) vs. the case of Terri (Schiavo). Mayo Clin Proc. 2006; 81(9):1155-1158.
26. Lenzer J. Unnecessary care: are doctors in denial and is profit driven healthcare to blame? BMJ. 2012; 345:e6230.
27. Riley G, Lubitz J. Long-term trends in Medicare payments in the last year of life. Health Serv Res. 2010; 42(2):565-576.
28. Jennings B, Morrissey MB. Health care costs in end-of-life and palliative care: the quest for ethical reform. J Soc Work End Life Palliat Care. 2011; 7(4):300-317.
29. Huynh TN, Kleerup EC, Wiley JF, et al. The frequency and cost of treatment perceived to be futile in critical care. JAMA Intern Med. 2013; 173(20):1887-189.
30. de Boer MJ, van der Wall EE. Choosing wisely or beyond the guidelines. Neth Heart J. 2013; 21(1):1-2.
31. Austin B, Fleisher L. Financing End-of-Life Care: Challenges for An Aging Population. Changes in Health Care Financing & Organization. 2003. http://www.hcfo.org/pdf/eolcare.pdf. Accessed August 19, 2013.
32. Baily MA. Futility, autonomy, and cost in end-of-life care. J Law Med Ethics. 2011; 39(2):172-182.
33. Goodman D, Fisher E, Chang C-H, et al. Quality of End-of-Life Cancer Care for Medicare Beneficiaries: Regional and Hospital- Specific Analyses. Hanover, NH: The Dartmouth Institute for Health Policy and Clinical Practice; 2010.
http://www.dartmouthatlas.org/downloads/reports/Cancer_report_11_16_10.pdf
 Accessed August 19, 2013.
34. Clark C. End-of-Life Care Is Often Futile, Costly. Health-Leaders Media. 2010. http://www.healthleadersmedia.com/content/QUA-259246/EndofLife-Care-is-Often-Futile-Costly.html  Accessed August 19, 2013.
35. Neuberg GW. The cost of end-of-life care: a new efficiency measure falls short of AHA/ACC standards. Circ Cardiovasc Qual Outcomes. 2009; 2(2):127-133.
36. Siddiqui M, Rajkumar SV. The high cost of cancer drugs and what we can do about it. Mayo Clin Proc. 2012;87(10):935-943.
37. Rosamond T. The high cost of cancer drugs and what we can do about it. Mayo Clin Proc. 2013; 88(3):306.
38. Rodriguez KL, Young AJ. Perceptions of patients on the utility or futility of end-of-life treatment. J Med Ethics. 2006; 32(8): 444-449.
39. Truog RD, White DB. Futile treatments in intensive care units. JAMA Intern Med. 2013; 173(20):1894-1895.
40. Dragsted L, Qvist J. Epidemiology of intensive care. Int J Technol Assess Health Care. 1992; 8(3):395-407.
41. Burrows RC, Hodgson RE. De facto gatekeeping and informed consent in intensive care. Med Law. 1997; 16(1):17-27.
42. Shiner K. Medical futility: a futile concept? Wash Lee Law Rev.1996; 53(2):803-48.
43. Luce JM. End-of-life decision making in the intensive care unit. Am J Respir Crit Care Med. 2010; 182(1):6-11.
44. Curiel TJ. Murder or mercy? Hurricane Katrina and the need for disaster training. N Engl J Med. 2006; 355(20): 2067-2069.
45. Model uniform core criteria for mass casualty triage. Disaster Med Public Health Prep. 2011; 5(2):125-128.
46. Lerner EB, Cone DC, Weinstein ES, et al. Mass casualty triage: an evaluation of the science and refinement of a national guideline. Disaster Med Public Health Prep. 2011; 5(2):129-137.
47. Furrow B, Greaney T, Johnson S, Jost T, Schwartz R, eds. Decision Making for Newborns: Note on Treating Seriously Ill Newborns. 6th ed. St. Paul, MN: Thompson/West; 2008:362-365.
48. Hook CC, Mueller PS. The Terri Schiavo saga: the making of a tragedy and lessons learned. Mayo Clin Proc. 2005; 80(11): 1449-1460.
49. Combs MP, Rasinski KA, Yoon JD, Curlin FA. Substituted judgment in principle and practice: a national physician survey. Mayo Clin Proc. 2013; 88(7):666-673.
50. Jesus JE, Allen MB, Michael GE, et al. Preferences for resuscitation and intubation among patients with do-not-resuscitate/donot- intubate orders. Mayo Clin Proc. 2013; 88(7):658-665.
51. Smith ML, Gremillion G, Slomka J, Warneke CL. Texas hospitals’experience with the Texas Advance Directives Act. Crit Care Med. 2007; 35(5):1271-1276.
52. Rubin MA, Dhar R, Diringer MN. Racial differences in withdrawal of mechanical ventilation do no alter mortality in neurologically injured patients. J Crit Care. 2014; 29(1):49-53.
53. Truog RD. Counterpoint: the Texas advance directives act is ethically flawed: medical futility disputes must be resolved by a fair process. Chest. 2009; 136(4):968-971.
54. Prasad V, Vandross A, Toomey C, et al. A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin Proc. 2013; 88(8):790-798.
55. Rivera S, Kim D, Garone S, Morgenstern L, Mohsenifar Z. Motivating factors in futile clinical interventions. Chest. 2001; 119(6):1944-1947.
56. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345(20):1435-1443.
57. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241-2251.
58. Barbara DW, Wetzel DR, Pulido JN, et al. The perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. Mayo Clin Proc. 2013; 88(7):674-682.
59. Avalli L, Maggioni E, Formica F, et al. Favourable survival of inhospital compared to out-of-hospital refractory cardiac arrest patients treated with extracorporeal membrane oxygenation: an Italian tertiary care centre experience. Resuscitation. 2012; 83(5):579-583.
60. Kagawa E, Inoue I, Kawagoe T, et al. Assessment of outcomes and differences between in- and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life support. Resuscitation. 2010; 81(8):968-973.
61. McMahon MM, Hurley DL, Kamath PS, Mueller PS. Medical and ethical aspects of long-term enteral tube feeding. Mayo Clin Proc. 2005; 80(11):1461-1476.
62. Fugate JE, Burns JD, Wijdicks EF, Warner DO, Jankowski CJ, Rabinstein AA. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe? Anesth Analg. 2010; 111(6):1520-1524.
63. Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology. 1989;71(5): 653-659.
64. Bebawy JF. Perioperative steroids for peritumoral intracranial edema: a review of mechanisms, efficacy, and side effects. J Neurosurg Anesthesiol. 2012; 24(3):173-177.
65. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury: outcomes at 6 months. Lancet. 2005; 365(9475):1957-1959.
66. Norris JW. Steroid therapy in acute cerebral infarction. Arch Neurol. 1976; 33(1):69-71.
67. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996; 71(8):801-812.
68. Hatakeyama S, Tachibana A, Suzuki K, Okano H. [Treatment of aspiration pneumonia with low-dose methylprednisolone and antibiotics]. Nihon Kyobu Shikkan Gakkai Zasshi. 1995; 33(1):51-56.
69. Ribaudo CA, Grace WJ. Pulmonary aspiration. Am J Med. 1971; 50(4):510-520.
70. Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005; 352(2):135-145.
71. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002; 346(8): 549-556.
72. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; 346(8):557-563.
73. Lanier WL. Cerebral metabolic-rate and hypothermia: their relationship with ischemic neurologic injury. J Neurosurg Anesth. 1995; 7(3):216-221.
74. Nolan JP, Morley PT, Vanden Hoek TL, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003; 108(1):118-121.
75. Wass CT, Lanier WL. Hypothermia-associated protection from ischemic brain injury: implications for patient management. Int Anesthesiol Clin. 1996; 34(4):95-111.
76. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013; 1: CD003311.
77. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353(15):1574-1584.
78. Beck EJ, Avila C, Gerbase S, Harling G, De Lay P. Counting the cost of not costing HIV health facilities accurately pay now, or pay more later. Pharmacoeconomics. 2012; 30(10): 887-902.
79. Hendrix CW. The clinical pharmacology of antiretrovirals for HIV prevention. Curr Opin HIV AIDS. 2012; 7(6):498-504.
80. Llibre JM, Clotet B. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment. AIDS Rev. 2012; 14(3):168-178.
81. Vanham G, Van Gulck E. Can immunotherapy be useful as a “functional cure” for infection with human immunodeficiency virus-1? Retrovirology. 2012; 9:72.
82. Allen MC, Donohue PK, Dusman AE. The limit of viability: neonatal outcome of infants born at 22 to 25 weeks’ gestation. N Engl J Med. 1993; 329(22):1597-1601.
83. McElrath TF, Robinson JN, Ecker JL, Ringer SA, Norwitz ER. Neonatal outcome of infants born at 23 weeks’ gestation. Obstet Gynecol. 2001; 97(1):49-52.
84. MacDonald H, American Academy of Pediatrics Committee on Fetus and Newborn. Perinatal care at the threshold of viability. Pediatrics. 2002; 110(5):1024-1027.
85. Batton DG, Committee on Fetus and Newborn. Clinical report -antenatal counseling regarding resuscitation at an extremely low gestational age. Pediatrics. 2009; 124(1):
422-427.
86. Wu MY, Liu YC, Tseng YH, Chang YS, Lin PJ, Wu TI. Pulmonary embolectomy in high-risk acute pulmonary embolism: the effectiveness of a comprehensive therapeutic algorithm including extracorporeal life support. Resuscitation. 2013; 84(10):136-170.
87. Wu MY, Tseng YH, Chang YS, Tsai FC, Lin PJ. Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization. Resuscitation. 2013; 84(7): 940-945.
88. Berg RA, Hemphill R, Abella BS, et al. Part 5: adult basic life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122(18 suppl 3):S685-S705.
89. Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122(18 suppl 3):S729-S767.
90. Harmon K. How has Stephen Hawking lived to 70 with ALS? Scientific American. 2012. http://www.scientificamerican.com/article.cfm?id¼stephen-hawking-als.
Accessed September 28, 2013.
91. Christopher & Dana Reeve Foundation. The costs of living with SCI (Spinal Cord Injury). 2011. http://www.christopherreeve.org/site/c.mtKZKgMWKwG/b.5193227/k.AFB/Costs_of_Living_with_Spinal_Cord_Injury.htm  Accessed September 28, 2013.
92. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med. 1990; 323(17):1209-1209.
93. Miller SM. Methylprednisolone in acute spinal cord injury: a tarnished standard. J Neurosurg Anesthesiol. 2008; 20(2):140-142.
94. Rajkumar SV. Treatment of myeloma: Cure vs control. Mayo Clin Proc. 2008; 83(10):1142-1145.
95. Bebbington MW, Danzer E, Johnson MP, Adzick NS. Open fetal surgery for myelomeningocele. Prenat Diagn. 2011; 31(7):689-694.
96. Clayton DB, Brock JW, 3rd. In utero intervention for urologic diseases. Nat Rev Urol. 2012; 9(4):207-217.
97. Deprest JA, Flake AW, Gratacos E, et al. The making of fetal surgery. Prenat Diagn. 2010; 30(7):653-667.
98. Van Aerschot I, Rosenblatt J, Boudjemline Y. Fetal cardiac interventions: myths and facts. Arch Cardiovasc Dis. 2012; 105(6-7):366-372.
99. Pope TM. Legal briefing: medical futility and assisted suicide. J Clin Ethics. 2009; 20(3):274-286.
100. Burkle CM, Benson JJ. End-of-life care decisions: importance of reviewing systems and limitations after 2 recent North American cases. Mayo Clin Proc. 2012; 87(11):1098-1105.
101. Swetz KM, Crowley ME, Hook C, Mueller PS. Report of 255 clinical ethics consultations and review of the literature. Mayo Clin Proc. 2007; 82(6):686-691.
102. Tapper EB, Vercler CJ, Cruze D, Sexson W. Ethics consultation at a large urban public teaching hospital. Mayo Clin Proc. 2010; 85(5):433-438.
103. Swetz KM, Hook CC, Henriksen Hellyer JM, Mueller PS. Health care ethics consultation competences and standards: a roadmap still needing a compass. Am J Bioeth. 2013; 13(2):20-22.
104. Aulisio MP, Chaitin E, Arnold RM. Ethics and palliative care consultation in the intensive care unit. Crit Care Clin. 2004; 20(3):505-523, x-xi.
105. Childers JW, Demme R, Greenlaw J, King DA, Quill T. A qualitative report of dual palliative care/ethics consultations: intersecting dilemmas and paradigmatic cases. J Clin Ethics. 2008;19(3): 204-213.
106. Gilmer T, Schneiderman LJ, Teetzel H, et al. The costs of nonbeneficial
treatment in the intensive care setting. Health Aff (Millwood). 2005; 24(4):961-971.
107. Tex. Health & Safety Code, x166.046. Procedure if not effectuating a directive or treatment decision. http://www.statutes.legis.state.tx.us/SOTWDocs/HS/htm/HS.166.htm#166.046.
Accessed January 17, 2014.
108. Zientek DM. The Texas Advance Directives Act of 1999: an exercise in futility? HEC Forum. 2005; 17(4):245-259.
109. Murphy DJ. Do-not-resuscitate orders: time for reappraisal in long-term-care institutions. JAMA. 1988; 260(14): 2098-2101.
110. Fine RL. Point: the Texas advance directives act effectively and ethically resolves disputes about medical futility. Chest. 2009; 136(4):963-967.
111. Miles SH. Informed demand for “non-beneficial” medical treatment. N Engl J Med. 1991; 325(7):512-515.
112. Pope TM, Waldman A. Mediation at the end of life: getting beyond the limits of the talking cure. Ohio State J Dispute Resolution. 2007;23(1):143-195.
113. Pope TM. Legal briefing: futile or non-beneficial treatment. J Clin Ethics. 2011; 22(3): 277-296.
114. In Re Emergency Guardianship of Albert N. Barnes, No. 27-GC-PR-111-16, District Probate Division, 4th Judicial district of the County of Hennepin, State of Minnesota. 2011. http://www.thaddeuspope.com/images/Barnes_Court_Ruling_02-04-11.pdf. Accessed January 17, 2014.
115. Olson J. End-of-life health care debated in Minnesota case. Standard-Examiner. January 31, 2011. http://www.standard. net/topics/health/2011/01/31/end-life-health-care-debatedminnesota-case Accessed January 17, 2014.
116. Gilgunn v. Massachusetts General Hospital. Suffolk County Superior
Court (42). 1995.
117. In Re the conservatorship of Helga M. Wanglie, No. PX-91-283, District Probate Division, 4th Judicial District of the County of Hennepin, State of Minnesota. 1991.
118. Betancourt v. Trinitas. Superior Court of New Jersey, A-3849-08T2. 1 A.3d 823 (N.J.Super.A.D. 2010). 2010.
119. Angell M. The case of Helga Wanglie: a new kind of “right to die” case. N Engl J Med. 1991; 325(7):511-512.
120. Payne E, Shoichet CE, Hanna J. Brain-dead girl Jahi McMath released from California hospital. CNN Health. January 7, 2014. http://www.cnn.com/2014/01/06/health/jahi-mcmathgirl-brain-dead/. Accessed January 17, 2014.
121. Wilson J. When routine surgeries go wrong. December 19, 2013. http://www.cnn.com/2013/12/19/health/routine-surgerycomplications/ Accessed January 17, 2014.
122. Swetz KM, Kuczewski MG, Mueller PS. Surrogate decision making and the need for advance care planning: issues raised by the Al Barnes case. Minn Med. 2011; 94(4):43-46.
123. Sniderman A, Lachapelle K, Rachon N, Furberg C. The necessity of clinical reasoning in the era of evidence-based medicine. Mayo Clin Proc. 2013; 88(10):1108-1114.
124. Lanier WL. Medical interventions at the end of life: what is appropriate and who is responsible? Mayo Clin Proc. 2005; 80(11):1411-1413.
125. Smith AK, Lo B, Sudore R. When previously expressed wishes conflict with best interests. JAMA Intern Med. 2013; 173(13): 1241-1245.
126. Sulmasy DP, Snyder L. Substituted interests and best judgments: an integrated model of surrogate decision making. JAMA. 2010; 304(17):1946-1947.
127. Sudore RL, Fried TR. Redefining the “planning” in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010; 153(4):256-261.
128. McMahan RD, Knight SJ, Fried TR, Sudore RL. Advance care planning beyond advance directives: perspectives from patients and surrogates. J Pain Symptom Manage. 2013; 46(3): 355-365.
129. Pellegrino ED. Medical ethics in an era of bioethics: resetting the medical profession’s compass. Theor Med Bioeth. 2012; 33(1):21-24.
130. Black BS, Fogarty LA, Phillips H, et al. Surrogate decision makers’ understanding of dementia patients’ prior wishes for end-of-life care. J Aging Health. 2009; 21(4):627-650.
131. Wright AA, Zhang B, Ray A, et al. Associations between end of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300(14):1665-1673.
132. Berger JT, DeRenzo EG, Schwartz J. Surrogate decision making:
reconciling ethical theory and clinical practice. Ann Intern Med. 2008; 149(1):48-53.
133. Perkins HS. Controlling death: the false promise of advance directives.
Ann Intern Med. 2007; 147(1):51-57.
134. Nishimura A, Mueller PS, Evenson LK, et al. Patients who complete
advance directives and what they prefer. Mayo Clin Proc. 2007; 82(12):1480-1486.
135. Patients Rights Council. Background about Euthanasia in the Netherlands. 2013. http://www.patientsrightscouncil.org/site/holland-background/. Accessed January 17, 2014.
136. American Medical Association. Code of Medical Ethics: Current Opinions with Annotations. Chicago, IL: American Medical Association; 2010-2011.
137. Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs. JAMA. 1999;281(10): 937-941

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024